GCC1: A Potential Drug Target for Cancer and Other Diseases (G79571)

Target Name: GCC1

NCBI ID: G79571

GCC1

GCC1: A Potential Drug Target for Cancer and Other Diseases

GCC1 (GCC1_HUMAN) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. GCC1 is a non-coding RNA molecule that has been shown to play a role in the regulation of cell growth and differentiation.

GCC1 is expressed in almost all human tissues and is highly conserved across different species. It is located on chromosome 6p and has been shown to be involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

One of the key functions of GCC1 is its role in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells in the body. However, in some diseases, such as cancer, the failure of apoptosis can lead to the formation of cancer cells.

GCC1 has been shown to play a role in the regulation of apoptosis by promoting the expression of genes that are involved in the process. For example, GCC1 has been shown to induce the expression of genes that are known to play a role in the regulation of apoptosis, such as Bcl-2 and p53. These genes have been shown to promote the formation of apoptosis-resistant cells, which can help to prevent the formation of cancer cells.

Another function of GCC1 is its role in the regulation of cell growth. GCC1 has been shown to play a role in the regulation of cell proliferation by promoting the expression of genes that are involved in cell growth and division. For example, GCC1 has been shown to induce the expression of genes that are known to play a role in cell growth and division, such as Myc.

GCC1 has also been shown to play a role in the regulation of inflammation. GCC1 has been shown to promote the production of pro-inflammatory cytokines by immune cells, such as T cells and macrophages. This increase in pro-inflammatory cytokines can contribute to the development of inflammatory diseases, such as cancer.

Despite its potential as a drug target or biomarker, GCC1 is still a relatively unexplored gene. Further research is needed to fully understand its functions and the potential implications of targeting GCC1 in cancer and other diseases.

In conclusion, GCC1 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its functions include the regulation of cell apoptosis, growth, and inflammation. Further research is needed to fully understand its potential implications and to develop effective treatments for these diseases.

Protein Name: GRIP And Coiled-coil Domain Containing 1

Functions: Probably involved in maintaining Golgi structure

The "GCC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GCC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets